THC Biomed Intl Ltd. Stock Analysis THC.CN
THC BioMed International Ltd. engages in the research, development and cultivation of medical cannabis. The company is headquartered in Kelowna, British Columbia and currently employs 35 full-time employees. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act, which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The firm operates in a single reportable segment, being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.
Read More THC Biomed Intl Ltd (THC.CN) Chart
Key Statistics of THC Biomed Intl Ltd (THC.CN)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
CAD0.03Volume
25.13KP/E Ratio (TTM)
-Market Cap
3.27MAvg. Volume
25.59KDividend Yield
-Financial Metrics & Statements of THC Biomed Intl Ltd (THC.CN)
FAQ's for THC Biomed Intl Ltd (THC.CN)
- According to Musaffa’s Shariah screening methodology, THC Biomed Intl Ltd (THC.CN) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.